IDEXX Laboratories, Inc.
IDXX Healthcare Diagnostics & Research
IDEXX Laboratories, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, up 10.4% from fiscal 2024. In the quarter to June 2026, revenue grew 9.66%, EPS grew 17.2%, free cash flow grew 111.4% and total debt fell 14.3%, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; revenue growth for ten consecutive years, operating cash flow growth for three.
Follow IDXX
IDEXX Laboratories, Inc. (IDXX) P/E ratio
As of 16 October 2026, IDEXX Laboratories, Inc. (IDXX) trades at a P/E ratio of 39.1×. Over the past ten years it has ranged from 31.2× (January 2016) to 85.8× (December 2020); the current reading is higher than 11% of that period. That is above the Diagnostics & Research industry median of 35.6× and above the Healthcare sector median of 23.0×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 51.3× | 33.71% |
| FY2024 | 38.4× | (28.72%) |
| FY2023 | 53.9× | 7.70% |
| FY2022 | 50.0× | (33.63%) |
| FY2021 | 75.3× | 2.64% |
| FY2020 | 73.4× | 39.42% |
| FY2019 | 52.6× | 22.55% |
| FY2018 | 43.0× | (18.33%) |
| FY2017 | 52.6× | 10.93% |
| FY2016 | 47.4× | 34.94% |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 36.7× | (10.43%) |
| Mar 2026 | 41.0× | (20.10%) |
| Dec 2025 | 51.3× | 2.12% |
| Sep 2025 | 50.3× | 13.50% |
| 42 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| NTRA Natera, Inc. compare | n/m |
| DGX Quest Diagnostics Incorporated compare | 24.6× |
| LH Labcorp Holdings Inc. compare | 26.2× |
| IQV IQVIA Holdings Inc. compare | 32.8× |
| A Agilent Technologies, Inc. compare | 34.0× |
| MTD Mettler-Toledo International, Inc. compare | 36.4× |
| IDXX IDEXX Laboratories, Inc. | 39.1× |
| ILMN Illumina, Inc. compare | 48.4× |
| WAT Waters Corporation compare | 109× |
| Diagnostics & Research industry median | 35.6× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)
More on IDXX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement